Product Description
Irinotecan HCL Trihydrate is a chemotherapeutic agent used to treat colon and rectal cancer in patients with advanced colorectal cancer. This injection solution contains Irinotecan Hydrochloride Trihydrate as the active ingredient. The dosage of Irinotecan HCL Trihydrate depends on the patients body surface area and condition, typically ranging from 125 mg/m to 350 mg/m. It is administered intravenously as prescribed by the doctor and comes in a single vial of specified concentration. This medicine should be stored below 25C, protected from light, and should not be frozen. Irinotecan HCL Trihydrate is a synthetic medicine packed in a single vial for adult patients.
FAQs of Irinotecan HCL Trihydrate:
Q: What is the recommended usage of Irinotecan HCL Trihydrate?
A: The dosage of Irinotecan HCL Trihydrate depends on the patients body surface area and condition.
Q: How should Irinotecan HCL Trihydrate be administered?
A: Irinotecan HCL Trihydrate should be administered intravenously as prescribed by the doctor.
Q: How should Irinotecan HCL Trihydrate be stored?
A: Irinotecan HCL Trihydrate should be stored below 25C, protected from light, and should not be frozen.
Q: What is the physical form of Irinotecan HCL Trihydrate?
A: Irinotecan HCL Trihydrate is in the form of an injection solution.
Q: What is the origin of Irinotecan HCL Trihydrate?
A: Irinotecan HCL Trihydrate is a synthetic medication.